The president-elect's words rattled the sector, though Amgen appears to be shrugging off his remarks.
These stocks are down some 20% over the last 30 months and look ripe for a rise.
Add to longs on a short-term correction.
Trade-Ideas LLC identified Repligen (RGEN) as a weak on high relative volume candidate
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.